ATTOHealthcare
Attovia Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Attovia Therapeutics, Inc. (ATTO), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ATTO insiders buying or selling?
In the last 12 months, Attovia Therapeutics, Inc. insiders reported 8 open-market purchases ($63.9M) and 0 sales ($0) — net buying of $63.9M. Since August 2026, Trabud has recorded 8 Form 4 filings for ATTO: 8 buys ($63.9M) and 0 sells ($0).
Source: SEC EDGAR Form 4
Key Statistics (August 2026 – Aug 28, 2026)
Total Form 4 filings
8
SEC EDGAR
Insider filers
6
Insider buys (8)
$63.9M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $63.9M in net buying since August 2026, and $63.9M in net buying over the last 12 months. 8 insider buys in the last 90 days.
Recent ATTO insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Colin Walsh | Director | Purchase | 479.2K | $16.76 | $8.0M | SEC ↗ |
| Aug 28, 2026 | GOLDMAN SACHS GROUP INC | Other | Purchase | 479.2K | $16.76 | $8.0M | SEC ↗ |
| Aug 14, 2026 | Colin Walsh | Director | Purchase | 479.2K | $16.76 | $8.0M | SEC ↗ |
| Aug 14, 2026 | GOLDMAN SACHS GROUP INC | Other | Purchase | 479.2K | $16.76 | $8.0M | SEC ↗ |
| Aug 10, 2026 | venBio Global Strategic Fund IV, L.P. | 10% Owner | Purchase | 382.4K | $17.00 | $6.5M | SEC ↗ |
| Aug 8, 2026 | Jeremy Green | 10% Owner | Purchase | 600.0K | $17.00 | $10.2M | SEC ↗ |
| Aug 7, 2026 | Sanofi | 10% Owner | Purchase | 300.0K | $17.00 | $5.1M | SEC ↗ |
| Aug 6, 2026 | Frazier Life Sciences XI, L.P. | 10% Owner | Purchase | 588.2K | $17.00 | $10.0M | SEC ↗ |
Showing the 8 most recent of 8 Form 4 filings for Attovia Therapeutics, Inc..
Most active ATTO insiders
- Colin Walsh2 filings
- GOLDMAN SACHS GROUP INC2 filings
- Frazier Life Sciences XI, L.P.1 filing
- Jeremy Green1 filing
- Sanofi1 filing
Ask anything about ATTO insider activity
Use Trabud's AI agent to query Attovia Therapeutics, Inc.'s Form 4 history in plain English — "Show me ATTO CEO purchases this year" or compare it against any other ticker.
Open the AI agentATTO insider trading FAQ
Are Attovia Therapeutics, Inc. insiders buying or selling?
In the last 12 months, Attovia Therapeutics, Inc. insiders reported 8 open-market purchases ($63.9M) and 0 sales ($0) — net buying of $63.9M. Since August 2026, Trabud has recorded 8 Form 4 filings for ATTO: 8 buys ($63.9M) and 0 sells ($0). Over the full record that is net buying of $63.9M.
How many insiders trade ATTO stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Attovia Therapeutics, Inc.. The most recent filing was accepted on Aug 28, 2026.
Where does Trabud get ATTO insider trading data?
All ATTO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.